| 所在主题: | |
| 文件名: 2010年武汉大学考博英语真题及答案解析.pdf | |
| 资料下载链接地址: https://bbs.pinggu.org/a-1382591.html | |
| 附件大小: | |
|
PASS11帮助手册绝对是学习计算样本量最好的材料,它不仅仅是帮助如何使用PASS,更从理论等各方面详细说明了样本量计算的方法,过程,如果想学习样本量计算,大家可以下载。
简单向在家举个例子,在临床随机对照试验时,我们要采用非劣效试验,那么如何计算非劣效试验的样本量呢? 下面看本手册里的具体分析: 在Survival analysis下的logrank tests for non-inferiority下查看内容如下: Introduction This module computes the sample size and power for non-inferiority tests under the assumption of proportional hazards. Accrual time and follow-up time are included among the parameters to be set. The non-inferiority logrank test is used for data analysis. Sometimes, the objective of a study is to show that an experimental therapy is not inferior to (no worse than) the standard therapy. The experimental therapy may be cheaper, less toxic, or have fewer side effects. Such studies are often called non-inferiority trials and have a one-sided hypothesis. Power and sample size calculations for the non-inferiority logrank test have been developed by Jung et al. (2005), and we use their results. These calculations assume an underlying exponential survival distribution with a uniform patient accrual pattern during the accrual period. Technical Details Test Statistic Suppose a clinical trial consists of two independent groups. Designate group one as the standard group with hazard rate h1 and sample size n1. Designate group two as the experimental group with hazard rate h2 and sample size n2. The total sample size is N = n1+n2 . Usually, you would plan to have n1=n2 . Define the proportion of the total sample in each group as Qi = ni/N, i=1,2 Individuals are recruited during an accrual period of R years (or months or days). They are followed for an additional period of time until a total of T years is reached. Hence, the follow-up period is T-R years. At the end of the study, the non-inferiority logrank test is conducted at significance level α with power 1− β . Under the proportion hazards assumption, the hazard ratio HR = h2 / h1 is constant across time. For a given non-inferiority margin HR0 (>1) (the maximum ratio of clinical insignificance), the statistical hypotheses tested are H0 : HR ≥ HR0 vs. H1 : HR < HR0 ....... 实际它把所有的计算过程都很详细的写了出来。 [hide][/hide] |
|
熟悉论坛请点击新手指南
|
|
| 下载说明 | |
|
1、论坛支持迅雷和网际快车等p2p多线程软件下载,请在上面选择下载通道单击右健下载即可。 2、论坛会定期自动批量更新下载地址,所以请不要浪费时间盗链论坛资源,盗链地址会很快失效。 3、本站为非盈利性质的学术交流网站,鼓励和保护原创作品,拒绝未经版权人许可的上传行为。本站如接到版权人发出的合格侵权通知,将积极的采取必要措施;同时,本站也将在技术手段和能力范围内,履行版权保护的注意义务。 (如有侵权,欢迎举报) |
|
京ICP备16021002号-2 京B2-20170662号
京公网安备 11010802022788号
论坛法律顾问:王进律师
知识产权保护声明
免责及隐私声明